Status:
RECRUITING
Sequelae of Sars-CoV-2 Infections
Lead Sponsor:
University of Giessen
Conditions:
Lung Diseases
Cardiac Disease
Eligibility:
All Genders
18+ years
Brief Summary
By the end of 2019 a new coronavirus, named SARS-CoV-2, was discovered in patients with pneumonia in Wuhan, China. In the following weeks and months the virus spread globally, having a tremendous impa...
Detailed Description
Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 requires hospitalization in a significant amount of patients. The hospitalization rate and disease severity increases in the elderly and patien...
Eligibility Criteria
Inclusion
- hospitalization due to Sars-CoV-2 infection
Exclusion
- under 18 years of age
Key Trial Info
Start Date :
May 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04442789
Start Date
May 20 2020
End Date
December 31 2025
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Internal Medicine II, Universities of Giessen and Marburg Lung Center (UGMLC), member of the German Center for Lung Research (DZL), Justus-Liebig-University
Giessen, Germany, 35392